By CIVICUS
May 7 2025 -
CIVICUS speaks about democratic decline in the USA with humanitarian and civil society activist Samuel Worthington, former president of the US civil society alliance Read more »
Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis
Freiburg, May 7th, 2025
Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat [...] Read more »
Dr. Falk Pharma gibt positive Ergebnisse seiner zulassungs-relevanten Phase-III-Studie zu Norucholsäure bei primär sklerosierender Cholangitis bekannt
Freiburg, den 7. Mai 2025
Die Studienergebnisse zeigen die Überlegenheit von Norucholsäure (NCA) gegenüber Placebo im kombinierten primären Endpunkt. Es gibt derzeit kein zugelassenes [...] Read more »
New Forms of Power-Sharing are Needed to Uphold Rights of Indigenous Peoples
By Simone Galimberti
KATHMANDU, [...] Read more »
Speaking Out for SRHR: Why Lived Experiences Must Shape Policy and Practice
Read more »
Does the UN’s Restructuring Negotiations Leave the Staff Union Out in the Cold?
By Thalif Deen
UNITED NATIONS, May 7 2025 - The [...] Read more »